ESA Council

Ann McCormackProfessor Ann McCormack (President) 

Department of Endocrinology | St Vincent’s Hospital | Sydney | NSW
Hormones and Cancer Group Leader | Garvan Institute of Medical Research | NSW
Conjoint Associate Professor | Faculty of Medicine | UNSW

A/Professor McCormack graduated in 2000 from the University of Sydney and undertook postgraduate training at the Royal North Shore Hospital. Her subsequent PhD examined the role of chemotherapy and genetic biomarkers in the management of aggressive pituitary tumours. In 2010 she completed a clinical and research fellowship in the Oxford Centre for Diabetes, Endocrinology and Metabolism, with a focus on pituitary tumours. She was then appointed to her current position as senior staff specialist in the Department of Endocrinology at St Vincent’s Hospital in 2011. She now also heads The Hormones and Cancer Group at the Garvan Institute of Medical Research. Her primary research interests are in exploring the biology of aggressive pituitary tumours and investigating new treatment options. She also has research interests in pituitary tumour genetics, particularly familial pituitary tumour syndromes. As a member for the European Society of Endocrinology’s Taskforce on Aggressive Pituitary Tumours, she was integral to the development of guidelines on the management of aggressive pituitary tumours published in 2017. She is board member of the International Pituitary Society, and holds other leadership positions within the pituitary field including chair of the St Vincent’s Campus pituitary multidisciplinary team, chair of the Sydney Pituitary Collaborative Group (SPCG) and co-chair of the Australia New Zealand Pituitary Alliance (ANZPA). 


Jenny GuntonProfessor Jenny Gunton (Treasurer)

Professor Jenny Gunton is the Director of the Centre for Diabetes and Obesity Research at the Westmead Institute for Medical Research and is Chair of Medicine at Westmead Hospital, University of Sydney.  Jenny received her PhD from the University of Sydney and completed her post-doctoral fellowship in Ron Kahn’s lab at the Joslin Diabetes Center, Harvard Medical School.  

Jenny’s research interests include diabetes, obesity, and vitamin D. She is particularly interested in the intersection of transcription factors and their regulation by nutrients including iron and Vitamin D. 



Professor Mathis Grossmann (Honorary Secretary)Mathis Grossman

University of Melbourne | VIC
Austin Health | VIC

Associate Professor Mathis Grossmann is a Principal Research Fellow at the Department of Medicine, University of Melbourne, Austin Health. He is a Consultant Endocrinologist and Head of Andrology at Austin Health, where he runs Endocrine Men’s Health and Endocrine Breast Cancer Clinics. He graduated with an MD from Heidelberg University Medical School and did his internship in Munich, Germany. He then spent 4 years in basic research at the National Institutes of Health, USA, and obtained a PhD at the Walter and Eliza Hall Institute in Melbourne, followed by clinical training leading to FRACP. He joined the University of Melbourne at Austin Health in 2006. His research focuses on the roles of reproductive hormones in health and disease. His group conducts observational and interventional trials in men with i) low testosterone and chronic disease, ii) hypogonadism, iii) prostate cancer receiving androgen deprivation therapy, and iv) women with breast cancer receiving aromatase inhibition to understand how reproductive hormones regulate musculoskeletal health and glucose homeostasis, both at the clinical and the molecular level.


Associate Professor (Peter) Shane Hamblin (President-elect)Shane Hamblin

Department of Endocrinology & Diabetes | Western Health | Sunshine Hospital | VIC 

Shane Hamblin is Head of Endocrinology & Diabetes at Western Health, Melbourne and a consultant endocrinologist at The Alfred, Melbourne. After graduating from Monash University, he trained in endocrinology & diabetes at The Alfred followed by two years at the University of Minnesota, Minneapolis USA, studying thyroid hormone action. He then worked for many years in private practice in Melbourne in addition to his public hospital appointments. He is an honorary Clinical Associate Professor (Principal Fellow) in the Department of Medicine- Western Precinct, Melbourne Medical School, The University of Melbourne and an Adjunct Senior Lecturer, Central Clinical School, Department of Medicine, Monash University. He is a member of the Pharmaceutical Benefits Advisory Committee. His main research interest is in clinical diabetes.

Fran MilatAssociate Professor Frances Milat

Deputy Director of Endocrinology | Monash Health | VIC
Metabolic Bone Services | Monash Health | VIC
Metabolic Bone Research Group | Hudson Institute of Medical Research | VIC
School of Clinical Sciences | Monash University | VIC

Frances is a Consultant Endocrinologist, Deputy Director of Endocrinology and Head of the Metabolic Bone Services at Monash Health, Head of the Metabolic Bone Research Group at the Hudson Institute and Adjunct Associate Professor in the School of Clinical Sciences, Monash University. Associate Professor Frances Milat is committed to improving patient care through clinical research, with interests in osteoporosis and metabolic bone disorders associated with chronic medical conditions including neurological disability, kidney disease, haematological disorders, early menopause and breast cancer. She is involved in the supervision of research students as well as medical student and postgraduate teaching.


Ada CheungDr Ada Cheung

Endocrinologist | NHMRC Research Fellow
Department of Medicine (Austin Health) | The University of Melbourne | VIC

Ada Cheung is an endocrinologist at Austin Health, Victoria and in private practice. She is currently an NHMRC and Dame Kate Campbell research fellow at The University of Melbourne. Following the completion of her PhD in andrology, over the last 4 years, Ada has established a Trans Health Research group. She has won a number of national and international awards for her research and community leadership including a US Endocrine Society Early Investigator Award and an Inspirational Woman Award for International Women’s Day 2020 at Austin Health. She led new national guidelines on the hormonal management of transgender individuals published in the Medical Journal of Australia in 2019. She is a Fellow of the Institute of Community Directors Australia attaining a Diploma of Business (Governance) in order to most effectively serve on boards. She serves on various professional organization committees and is an editorial board member for Journal of Clinical Endocrinology and Metabolism and Therapeutic Advances in Endocrinology and Metabolism.


Liz JohnstoneDr Liz Johnstone

Liz Johnstone obtained her PhD in Pharmacology from the University of Western Australia (UWA) in 2016. Since then she has been working as a postdoctoral researcher at the Harry Perkins Institute of Medical Research/UWA Centre for Medical Research where she studies the molecular pharmacology of receptors. In 2017, she spent a year working part time as Senior Project Officer for Accelerating Australia, a consortium dedicated to promoting biomedical innovation and entrepreneurship. In 2021 she was appointed as a Pharmacology Lecturer in the UWA School of Biomedical Sciences, while she continues her research at the Harry Perkins Institute of Medical Research. Liz was the inaugural Co-Chair (Science) of the ESA Early Career Committee from 2019-2022, and is also currently a member of the International Union of Pharmacology’s Early Career Committee.

Sunita De SousaAssociate Professor Sunita De Sousa

Endocrinology & Genetics | Royal Adelaide Hospital
Adelaide Medical School | University of Adelaide

 Assoc Prof Sunita De Sousa is a Staff Specialist in Endocrinology and Genetics at the Royal Adelaide Hospital. Her PhD examined genetic and clinical aspects of prolactinomas and was awarded the University of Adelaide Doctoral Research Medal. She has also completed an MSc at the University of London, and fellowships in pituitary endocrinology at St Vincent’s Hospital Sydney and clinical genetics in the SA Clinical Genetics Service. With ongoing funding from the ESA, RACP, MRFF and Royal Adelaide Hospital, her postdoctoral studies focus on monogenic diabetes and hereditary pancreatitis, and she was a co-author of the recent Australian hyperparathyroidism guidelines. Her current roles include PhD supervisor, reviewer for several journals, and member of the eviQ Cancer Genetics Committee and the US Endocrine Society Steering Committee for Endocrine Cancers Special Interest Group. She is the founding member of EndoGen, Australia’s national network of endocrine genetic centres. 


Roderick Clifton-BlighProfessor Roderick Clifton-Bligh

Head, Department of Endocrinology, Royal North Shore Hospital, St Leonards, Sydney
And Professor in Medicine, University of Sydney

Roderick Clifton-Bligh is Head of the Department of Endocrinology at Royal North Shore Hospital, and conjoint professor in Medicine at the University of Sydney. He trained in medicine at the University of Sydney before completing a PhD in the genetics of thyroid disorders at the University of Cambridge in 1998. He returned to Sydney to complete his FRACP in 2004 and was then appointed as Staff Specialist in Endocrinology at Royal North Shore Hospital. He is now senior staff specialist and Head of Department of Endocrinology at Royal North Shore Hospital and Professor (conjoint) at the University of Sydney. He heads the Cancer Genetics Laboratory at the Kolling Institute and direct twin research programs in Endocrine Neoplasia (Phaeochromocytoma/ paraganglioma syndromes, Thyroid Cancer, Adrenal Cancer, Pituitary Tumours) and Metabolic Bone Disease (calcium-sensing receptor function in health and disease, and FGF-23 regulation of vitamin D metabolism). He was admitted to Fellowship of Faculty of Science (The Royal College of Pathologists of Australia) in 2011. He has co-authored 198 publications in peer-reviewed journals with >6,000 citations. He has supervised 14 completed PhDs, including both basic science and clinical focused work; his students included the ESA Young Investigators in 2005, 2007, and 2010 and the ESA Bryan Hudson awardee in 2008. His work has been recognized by awards from NSW Cancer Institute (2013), Asia-Oceania Thyroid Association (2014) and the Endocrine Society of Australia Outstanding Clinical Practitioner Award (2021). His service to the Endocrine Society of Australia includes membership of the POC for its ASM in 2004-2006 and 2013-2015; and the ESA representative to the Specialist Advisory Committee in Endocrinology at the Royal Australasian College of Physicians from 2004-2012 (as chair, 2010-2012). He is passionate about scientific advancement in endocrinology through mentoring and training young physicians and scientists.

Dr Lisa HayesDr Lisa Hayes

Princess Alexandra Hospital , Brisbane

 Lisa Hayes is the Director of Endocrinology at the Princess Alexandra Hospital in Brisbane. She completed her endocrinology training in Brisbane. Lisa has a clinical interest in genetic endocrine conditions and established the QLD Statewide Combined Endocrine Genetics clinic in combination with the clinical genetics team at Genetic Health Queensland. She is a member of the eviQ Cancer Genetics Reference Committee and the EndoGen network of Australian Endocrine Genetic Centres. Lisa is passionate about teaching and mentoring endocrinology trainees. She has been organising the QLD NT Endocrine AT teaching series for the last 8 years and she is currently the co-chair of the QLD NT Endocrinology advanced trainee selection panel. She is also the co-chair for the QLD Quality in Diabetes Care meeting. Lisa is an associate fellow of the Royal Australian College of Medical Administrators and has an interest in workforce planning and improving staff wellbeing.




Mrs Ivone Johnson
See: Contact ESA page for details and contact form.